These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 10915423

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin.
    Ahmad J, Dodson SF, Demetris AJ, Fung JJ, Shakil AO.
    Liver Transpl; 2001 Oct; 7(10):863-9. PubMed ID: 11679984
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C.
    Shakil AO, McGuire B, Crippin J, Teperman L, Demetris AJ, Conjeevaram H, Gish R, Kwo P, Balan V, Wright TL, Brass C, Rakela J.
    Hepatology; 2002 Nov; 36(5):1253-8. PubMed ID: 12395337
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ribavirin: new preparation. An advance, but still no cure-all.
    Prescrire Int; 2000 Jun; 9(47):72-5. PubMed ID: 11010742
    [Abstract] [Full Text] [Related]

  • 11. [Evaluation of side effects of interferon-alpha in 72 patients treated for chronic active hepatitis C].
    Duché A, Decocq G, Capron-Chivrac D, Andréjak M.
    Therapie; 1995 Jun; 50(5):419-23. PubMed ID: 8571279
    [Abstract] [Full Text] [Related]

  • 12. Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: a pragmatic study.
    Alberti AB, Belli LS, Airoldi A, de Carlis L, Rondinara G, Minola E, Vangeli M, Cernuschi A, D'Amico M, Forti D, Pinzello G.
    Liver Transpl; 2001 Oct; 7(10):870-6. PubMed ID: 11679985
    [Abstract] [Full Text] [Related]

  • 13. Long-term follow-up after successful interferon therapy of acute hepatitis C.
    Wiegand J, Jäckel E, Cornberg M, Hinrichsen H, Dietrich M, Kroeger J, Fritsch WP, Kubitschke A, Aslan N, Tillmann HL, Manns MP, Wedemeyer H.
    Hepatology; 2004 Jul; 40(1):98-107. PubMed ID: 15239091
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
    Czerwionka-Szaflarska M, Chrobot A, Szaflarska-Szczepanik A.
    Med Sci Monit; 2000 Jul; 6(5):964-70. PubMed ID: 11208439
    [Abstract] [Full Text] [Related]

  • 16. Treatment of patients with hepatitis C and cirrhosis.
    Wright TL.
    Hepatology; 2002 Nov; 36(5 Suppl 1):S185-94. PubMed ID: 12407593
    [Abstract] [Full Text] [Related]

  • 17. Management of hepatitis C.
    NIH Consens Statement; 2002 Nov; 15(3):1-41. PubMed ID: 9457159
    [Abstract] [Full Text] [Related]

  • 18. The clinical application of the interferons: a review. NSW Therapeutic Assessment Group.
    Stuart-Harris RC, Lauchlan R, Day R.
    Med J Aust; 1992 Jun 15; 156(12):869-72. PubMed ID: 1376397
    [Abstract] [Full Text] [Related]

  • 19. Managing patients with hepatitis C.
    Drug Ther Bull; 1993 Aug 02; 31(16):61-2. PubMed ID: 8375275
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of chronic hepatitis B and hepatitis C with interferon alfa-2b.
    Molloy PJ, Azzouz M, Van Thiel DH.
    Am Fam Physician; 1996 Oct 02; 54(5):1598-605. PubMed ID: 8857782
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.